EMA's Revised Guideline On Medicines For Rheumatoid Arthritis Reflects New Endpoints
Executive Summary
Advances in the field of rheumatoid arthritis over the past decade have prompted the European Medicines Agency to review its approach to the clinical evaluation of drugs to treat this condition.